ICGEB gives emphasis to World Malaria Day, and this year’s theme: “Time to deliver zero malaria: invest, innovate, implement”.
Within this theme, the World Health Organization is focusing on – implement – and notably the critical importance of reaching marginalised populations with the tools and strategies that are available today.
- According to WHO’s World malaria report 2022, the funding gap between the amount invested in the global malaria response (US$ 3.5 billion) and the resources needed (US$ 7.3 billion) has widened, particularly over the past 3 years
- In this resource-constrained environment, a better targeting of available funding is essential. Funding should be prioritised for the most vulnerable populations who are less able to access services and hardest hit when they become ill.
What does ICGEB do?
ICGEB Scientists in six laboratories work on Malaria to understanding malaria parasites’ biology, and to identify new drug and vaccine candidate antigens. Our scientists work to design and develop new New anti-malarials and to build capacity within regions that are most susceptible to the disease.
Najneen Rejwana from Bangladesh moved to ICGEB New Delhi to design and develop new antimalarial drug compounds. She was recipient of an ICGEB EMPOWER Fellowship, funded by the United Nations Office for South South Cooperation.